Spire Healthcare Group (LON:SPI – Get Free Report) announced its quarterly earnings results on Wednesday. The company reported GBX (0.50) earnings per share (EPS) for the quarter, Digital Look Earnings reports. Spire Healthcare Group had a net margin of 1.04% and a return on equity of 2.22%.
Spire Healthcare Group Stock Up 0.4%
LON:SPI traded up GBX 1 during trading hours on Wednesday, reaching GBX 246.50. The company’s stock had a trading volume of 28,379,076 shares, compared to its average volume of 5,545,009. The stock has a 50 day moving average price of GBX 237.57 and a two-hundred day moving average price of GBX 207.17. The company has a debt-to-equity ratio of 177.14, a quick ratio of 0.73 and a current ratio of 0.63. The company has a market capitalization of £987.47 million, a P/E ratio of 61.62, a price-to-earnings-growth ratio of 1.06 and a beta of 0.93. Spire Healthcare Group has a 12 month low of GBX 140.80 and a 12 month high of GBX 251.50.
Analyst Upgrades and Downgrades
Separately, Royal Bank Of Canada downgraded Spire Healthcare Group to a “sector perform” rating and reduced their price objective for the stock from GBX 300 to GBX 250 in a report on Monday, September 7th. One analyst has rated the stock with a Buy rating and one has given a Hold rating to the company’s stock. According to data from MarketBeat, Spire Healthcare Group currently has a consensus rating of “Moderate Buy” and an average price target of GBX 247.50.
About Spire Healthcare Group
Spire Healthcare Group plc, together with its subsidiaries, owns and operates private hospitals and clinics. It offers various treatments in the areas of allergy and infectious diseases, blood tests, bones and joints, bowel treatments, breast screening and surgery, cancer investigations and treatments, cosmetic surgery, cyst removal, and dental surgery, as well as ear, nose, and throat treatments. The company also provides eye surgery and treatments, family planning, gastroenterology, general medicine, general surgery, haematology, hand surgery, hip and knee treatment, and heart and kidney treatments.
See Also
- Five stocks we like better than Spire Healthcare Group
- Deutsche Bank Makes a Contrarian Call on Netflix—What Does It Mean for Investors?
- O’Reilly Automotive’s Stock Slump Hides a Stronger Business
- McDonald’s Stock Slump Makes Its AI Pricing Bet Even Riskier
- Broadcom’s AI Growth Story Faces a $161 Billion Anthropic Test
Receive News & Ratings for Spire Healthcare Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Spire Healthcare Group and related companies with MarketBeat.com's FREE daily email newsletter.
